Compares treatment options for Shoulder Instability
Official title Modified PENG Plus Suprascapular Nerve Block Versus Interscalene Block for Bankart and Latarjet Surgery
ClinicalTrials.gov ID: NCT07689045
What this study is testing
- What it's testing
- This randomized controlled trial aims to compare the analgesic efficacy and safety of a Modified Pericapsular Nerve Group (PENG) Block combined with Suprascapular Nerve Block (SSNB) versus Interscalene Brachial Plexus Block (ISB) in adult patients undergoing elective Bankart repair or Latarjet surgery under general anesthesia. Seventy patients will be randomized to receive either Modified PENG plus SSNB or ISB.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Male or female patients aged 18 to 65 years.
- Patients undergoing elective Bankart repair or Latarjet surgery.
- American Society of Anesthesiologists (ASA) physical status I or II. Exclusion Patient refusal.
- History of allergy to local anesthetics.
- Chronic opioid use (\>3 months).
See the full eligibility criteria
- Male or female patients aged 18 to 65 years.
- Patients undergoing elective Bankart repair or Latarjet surgery.
- American Society of Anesthesiologists (ASA) physical status I or II. Exclusion Patient refusal.
- History of allergy to local anesthetics.
- Chronic opioid use (\>3 months).
- Coagulation disorders.
- Pre-existing neurological or musculoskeletal disorders.
- Respiratory compromise (e.g., COPD)
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.